151 related articles for article (PubMed ID: 17127330)
1. Ubiquitin-like protein modifications in prostate and breast cancer.
Wu F; Mo YY
Front Biosci; 2007 Jan; 12():700-11. PubMed ID: 17127330
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor- and PIAS1-regulated gene programs in molecular apocrine breast cancer cells.
Malinen M; Toropainen S; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
Mol Cell Endocrinol; 2015 Oct; 414():91-8. PubMed ID: 26219822
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.
Mukherjee S; Thomas M; Dadgar N; Lieberman AP; Iñiguez-Lluhí JA
J Biol Chem; 2009 Aug; 284(32):21296-306. PubMed ID: 19497852
[TBL] [Abstract][Full Text] [Related]
4. SUMO and estrogen receptors in breast cancer.
Karamouzis MV; Konstantinopoulos PA; Badra FA; Papavassiliou AG
Breast Cancer Res Treat; 2008 Jan; 107(2):195-210. PubMed ID: 17377839
[TBL] [Abstract][Full Text] [Related]
5. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
6. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
8. Regulation of post-translational modification in breast cancer treatment.
Heo KS
BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
[TBL] [Abstract][Full Text] [Related]
9. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation.
Treuter E; Venteclef N
Biochim Biophys Acta; 2011 Aug; 1812(8):909-18. PubMed ID: 21172431
[TBL] [Abstract][Full Text] [Related]
11. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
Mukherjee S; Cruz-Rodríguez O; Bolton E; Iñiguez-Lluhí JA
J Biol Chem; 2012 Sep; 287(37):31195-206. PubMed ID: 22829593
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation proteins in breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan C; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2014 Apr; 144(3):519-30. PubMed ID: 24584753
[TBL] [Abstract][Full Text] [Related]
14. Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis.
Subramonian D; Raghunayakula S; Olsen JV; Beningo KA; Paschen W; Zhang XD
J Proteome Res; 2014 Sep; 13(9):3905-18. PubMed ID: 25072996
[TBL] [Abstract][Full Text] [Related]
15. SUMO in the regulation of DNA repair and transcription at nuclear pores.
Gasser SM; Stutz F
FEBS Lett; 2023 Nov; 597(22):2833-2850. PubMed ID: 37805446
[TBL] [Abstract][Full Text] [Related]
16. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation in carcinogenesis.
Bettermann K; Benesch M; Weis S; Haybaeck J
Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of desumoylating enzymes.
Kim JH; Baek SH
Biochim Biophys Acta; 2009 Mar; 1792(3):155-62. PubMed ID: 19162180
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.
Chmelar R; Buchanan G; Need EF; Tilley W; Greenberg NM
Int J Cancer; 2007 Feb; 120(4):719-33. PubMed ID: 17163421
[TBL] [Abstract][Full Text] [Related]
20. The SUMO Pathway in Mitosis.
Mukhopadhyay D; Dasso M
Adv Exp Med Biol; 2017; 963():171-184. PubMed ID: 28197912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
